Cowealth Medical Holding Co Ltd - Asset Resilience Ratio
Cowealth Medical Holding Co Ltd (4745) has an Asset Resilience Ratio of 2.74% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Cowealth Medical Holding Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Cowealth Medical Holding Co Ltd's Asset Resilience Ratio has changed over time. See 4745 equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Cowealth Medical Holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cowealth Medical Holding Co Ltd (4745) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$192.64 Million | 2.74% |
| Total Liquid Assets | NT$192.64 Million | 2.74% |
Asset Resilience Insights
- Limited Liquidity: Cowealth Medical Holding Co Ltd maintains only 2.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cowealth Medical Holding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Cowealth Medical Holding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Cowealth Medical Holding Co Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Cowealth Medical Holding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.74% | NT$192.64 Million ≈ $6.07 Million |
NT$7.04 Billion ≈ $221.86 Million |
+2.01pp |
| 2024-12-31 | 0.72% | NT$50.14 Million ≈ $1.58 Million |
NT$6.96 Billion ≈ $219.23 Million |
-0.67pp |
| 2023-12-31 | 1.39% | NT$92.55 Million ≈ $2.92 Million |
NT$6.64 Billion ≈ $209.05 Million |
+0.78pp |
| 2022-12-31 | 0.61% | NT$44.10 Million ≈ $1.39 Million |
NT$7.21 Billion ≈ $227.06 Million |
-- |
About Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more